Buying peptides online: what the gray market actually ships.
The short answer
- Two kinds of sellers show up for the same search: clinics that require a prescription, and "research use only" sites that ship with no questions asked.
- In 2026, WIRED had four vials from a Brooklyn store tested. None was confirmed to contain the ingredient on its label.
- A "research use only" label is a legal shield, not a quality standard.
- Compounded medications are not FDA-approved. What a licensed clinic provides is a prescriber and a pharmacy legally accountable for what reaches you.

Who sells peptides online?
Search for semaglutide, sermorelin or BPC-157, and you will find two kinds of sellers sitting side by side in the results. One asks about your medical history, requires a prescription, and charges clinic prices. The other ships a vial with the same molecule name on the label, marked "for research use only," at a fraction of the cost, no questions asked.
The price gap is real. The question is what you are actually paying for. Independent laboratories have purchased and tested what the cheap vials contain, so this does not have to be a matter of opinion. This article walks through that evidence, explains how the tiers of peptide sellers differ legally and practically, and ends with a checklist you can use to vet any provider, including us. New to the topic? Start with our plain-English guide to what a peptide is.
"Research use only" vendors
These sites sell peptides as laboratory chemicals. No prescription, no pharmacist, no clinician, and a label that says "not for human consumption." That label is a legal shield, not a quality standard: it is an attempt to avoid being regulated as a drug seller. The FDA has stopped accepting the fiction. In December 2024 it sent warning letters to online peptide vendors selling semaglutide, tirzepatide and related compounds, writing that despite the research-use labels, the evidence showed the products were intended as drugs for human use.6 No agency verifies what is in these vials before they ship.
Licensed clinics working with licensed pharmacies
Here a US-licensed clinician reviews your health history and writes a patient-specific prescription, which is filled by a state-licensed compounding pharmacy (a 503A pharmacy, overseen by state boards of pharmacy with FDA inspection authority) or an FDA-registered 503B outsourcing facility, which must follow the same manufacturing standards as drug makers.7 This is the tier faber protocol operates in, through state-licensed 503A pharmacies. To be precise about what this tier is not: compounded medications are not FDA-approved products. What the tier provides is a regulated chain of custody, with a licensed prescriber and a licensed pharmacy legally accountable for what reaches you.
FDA-approved brand products
FDA-approved brand-name medicines have passed full FDA review of safety, effectiveness and manufacturing. This is the highest bar and the highest price, and for many patients insurance does not cover it.
What did independent labs find in gray market vials?
The most rigorous recent test came from a university research team that ordered semaglutide from six illegal online vendors and published the results in 2024 in JAMA Network Open and the Journal of Medical Internet Research.1 Three of the six orders never arrived at all; the sellers instead demanded fake "customs clearance" payments of $650 to $1,200. The three vials that did arrive were tested in a laboratory:
- Purity was 7% to 14%, against an advertised 99%.
- The actual semaglutide content was 29% to 39% higher than the labeled dose. With a potent metabolic drug, getting more than the label says is an overdose risk, not a bonus.
- Every delivered sample contained detectable bacterial endotoxins, which you do not want in anything you inject.
This is not a one-off. In 2018, Belgium's national health laboratory published an analysis of the falsified peptide drugs it encountered most often. Several samples exceeded safety limits for arsenic, in the worst case by roughly ten times.2 An earlier 2015 study bought melanotan II from three online shops: every vial was labeled 10 mg, and the actual content ranged from 4.3 to 8.8 mg, with unidentified impurities in most.3
The pattern across a decade of testing is consistent. With gray market peptides, the dose you draw into a syringe is unknown in both directions, and purity claims on the website bear no reliable relationship to the vial.
What did 2026 reporting find?
The 2026 reporting points the same way. In July, CBS News bought a vial labeled as an experimental weight-loss drug over the counter at a Brooklyn convenience store. No prescription, no questions. The lab named on the brand's certificate of analysis said it had never issued it.11
In September, WIRED had four vials from the same store tested. The labels read PT-141, BPC-157, NAD+ and retatrutide. None was confirmed to contain the ingredient on its label.12
In October, The Wall Street Journal reported that at least 50 Chinese chemical companies tracked for selling fentanyl ingredients now sell peptides.13 In November, Health Canada seized more than 11,400 vials from online peptide sellers after its lab found bacteria in them.14
Have counterfeits reached pharmacy shelves?
The problem is not limited to obscure websites. In December 2023 the FDA seized thousands of counterfeit units of an FDA-approved semaglutide pen that had entered the legitimate US drug supply chain, with further seizures announced in 2025.4 The World Health Organization issued a global alert in June 2024 covering falsified semaglutide found in the US, UK and Brazil, and noted rising reports worldwide since 2022, including counterfeit pens that contained undeclared insulin, which can cause dangerous hypoglycemia.8 If counterfeiters are willing to target regulated pharmacy channels, an unregulated website with no accountable pharmacist is a far softer target.
Where do people actually get hurt?
Contamination gets the headlines, but the most common way people are harmed is simpler: they inject the wrong amount. US poison control centers took nearly 3,000 calls involving semaglutide in the first eleven months of 2023, roughly fifteen times the 2019 level, and the majority involved dosing errors such as accidental double doses.9 The FDA's adverse event database held 990 reports associated with compounded semaglutide and more than 730 for compounded tirzepatide as of May 2026, including hospitalizations that may be related to dosing errors.5
A vial, an insulin syringe and no instructions is a unit conversion problem waiting to happen. This is the practical argument for clinician oversight: not gatekeeping, but titration schedules, unit math checked by a clinician, and someone to call when side effects appear.
What does a licensed clinic give you, and what does it not?
The FDA states plainly that it "does not verify the safety, effectiveness or quality of compounded drugs before they are marketed."7 Quality among compounding pharmacies varies. The regulatory environment for compounded GLP-1s specifically has tightened since the brand-drug shortages were declared resolved in 2024 and 2025, and in March 2026 the FDA sent warning letters to 30 telehealth companies over how they marketed compounded GLP-1s.10 Any clinic in this space owes you clarity about how it sources and tests what it sells.
What the licensed tier does provide: a clinician legally responsible for the prescription, a pharmacy legally responsible for the product, purity and sterility standards with inspection authority behind them, and a dosing protocol with follow-up. None of that exists in Tier 1 at any price.
What changed for BPC-157, TB-500 and KPV in 2026?
In 2023 the FDA listed BPC-157, TB-500, KPV and other peptides as a compounding safety concern. It removed them from that list in April 2026. On October 28, 2026, HHS issued an interim policy: it does not intend to act against licensed pharmacies and prescribers that compound six peptides, BPC-157 and TB-500 among them, under set conditions.15, 16 Those conditions include a patient-specific prescription and a documented ingredient source with a certificate of analysis. This is enforcement discretion, not FDA approval, and HHS can revise it. It does not extend to "research use only" sellers. Our guide to peptides has the full list of conditions.
What should you ask before you buy from anyone?
- Does a US-licensed clinician review my health history before I can order?
- Which pharmacy fills the prescription, and is it state-licensed or FDA-registered?
- Does the medication arrive from a US pharmacy, with my name and my prescriber on the label?
- Is the dose I receive labeled in mg, with a titration plan in writing?
- Is there a clinician I can reach if I have side effects?
- Does the seller claim its product is "FDA approved"? For compounded drugs, that claim is false and a red flag in itself.
- Does the label say "research use only"? If yes, no one has verified the vial's contents for human use. Walk away.
The bottom line
The discount on a gray market vial is not a discount on the same product. Published laboratory testing shows it is frequently a different product: underdosed, overdosed, impure, or not the labeled molecule at all. What a legitimate clinic charges for is the licensed chain of custody between a prescriber, a pharmacy and your syringe. That is the entire difference, and in this category it is the difference that matters. That is why we do not recommend research-use peptides to anyone, at any price.
Quick answers.
Is it legal to sell "research use only" peptides for human use?
No. The FDA treats them as unapproved drugs when the marketing shows they are meant for people, and it has sent warning letters to sellers on that basis.
Do I need a prescription to buy peptides online?
For therapeutic peptides, yes. A site that ships injectable peptides without one is selling them as research chemicals.
Are compounded peptides FDA-approved?
No. Compounded medications can be prescribed under federal law, but they do not go through FDA review of safety, effectiveness or manufacturing.
Why do clinic peptides cost more?
The price covers the clinician review, the licensed pharmacy and the follow-up. A research-use vial comes with none of them.
Sources (16)
- Ashraf AR, Mackey TK, Vida RG, et al. "Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases." JAMA Network Open, 2024, and Journal of Medical Internet Research, 2024. jamanetwork.com/...2821882, jmir.org/2024/1/e65440
- Janvier S, Cheyns K, Canfyn M, et al. "Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market." Talanta, 2018. repository.sciensano.be/...
- Breindahl T, Evans-Brown M, Hindersson P, et al. "Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet." Drug Testing and Analysis, 2015. pubmed.ncbi.nlm.nih.gov/24771717
- FDA. Counterfeit semaglutide alerts, December 2023, updated 2025. fda.gov/drugs/drug-alerts-and-statements/...
- FDA. "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss." Adverse event counts as of May 31, 2026. fda.gov/drugs/drug-alerts-and-statements/...
- FDA. Warning letter to an online peptide vendor, December 10, 2024. fda.gov/...warning-letters/...12102024
- FDA. "Compounding and the FDA: Questions and Answers." fda.gov/drugs/human-drug-compounding/...
- World Health Organization. Medical Product Alert No. 2/2024, falsified semaglutide, June 2024. who.int/news/item/20-06-2024...
- National Association of Boards of Pharmacy and America's Poison Centers. Semaglutide exposure calls, 2023. nabp.pharmacy/news/blog/...
- FDA. "FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s," March 3, 2026. fda.gov/news-events/press-announcements/...
- CBS News. "What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug," July 2, 2026. cbsnews.com/news/...
- WIRED. "Those Viral Bodega Peptides Aren't Actually Peptides," September 15, 2026.
- The Wall Street Journal. Report on Chinese chemical suppliers selling peptides, October 6, 2026, citing TRM Labs. trmlabs.com/resources/blog/...
- Health Canada. "Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs," November 6, 2026. recalls-rappels.canada.ca/...
- Federal Register. Notice 2026-22192, October 30, 2026. federalregister.gov/...2026-22192
- Holland & Knight. "HHS Issues Interim Enforcement Discretion Policy for Compounding of 6 Peptides," November 4, 2026. hklaw.com/insights/...
This article is educational and is not medical advice, diagnosis or a treatment recommendation. Study findings describe group averages and do not predict your result. Regulatory status can change; this page reflects the rules as of its update date. Prescription decisions at faber protocol are made by U.S. state-licensed clinicians after a review of your health history and, where indicated, laboratory testing.
The medicine is one part.
The protocol is the rest.
Every prescription comes with a plan for the habits around it.
Get started →